These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10224689)

  • 21. Second primary cancers after sporadic and familial colorectal cancer.
    Hemminki K; Li X; Dong C
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):793-8. PubMed ID: 11440965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].
    Nilbert M; Grönberg H; Lindblom A
    Lakartidningen; 2002 Aug; 99(34):3296-300. PubMed ID: 12362848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant melanoma in Puerto Rico: an update.
    González-Fernández M; Sánchez JL
    P R Health Sci J; 1999 Jun; 18(2):95-8. PubMed ID: 10461314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary non polyposis colorectal cancer].
    Dieumegard B
    Ann Med Interne (Paris); 2001 Sep; 152(5):317-21. PubMed ID: 11593143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-polyposis colorectal cancer in subjects under 55 years of age: frequency and phenotype of hereditary or familial syndromes].
    Di Betta E; Nascimbeni R; Ghirardi M; Alba S; Salerni B
    Ann Ital Chir; 2000; 71(2):217-24; discussion 225. PubMed ID: 10920494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications].
    Weitz J; Knaebel HP; Büchler MW
    Chirurg; 2003 Aug; 74(8):717-25. PubMed ID: 12928792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary nonpolyposis colorectal cancer (Lynch syndrome): a review of the literature and case reports].
    Lucci S; Pasta V; Arcieri S; Rivolta R; Candioli S; Manigrasso A; Papetti MT; Cerutti L; Merlino G
    G Chir; 2000 Apr; 21(4):177-87. PubMed ID: 10812774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing in hereditary colorectal cancer: indications and procedures.
    Terdiman JP; Conrad PG; Sleisenger MH
    Am J Gastroenterol; 1999 Sep; 94(9):2344-56. PubMed ID: 10483990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
    Möslein G
    Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorectal cancer: when and how to look for hereditary nonpolyposis colorectal neoplasm syndrome?].
    Jaïs P
    Gastroenterol Clin Biol; 1999 Feb; 23(2):284-6. PubMed ID: 10353029
    [No Abstract]   [Full Text] [Related]  

  • 35. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic risk factors in colorectal cancer.
    Bonaïti-Pellié C
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S27-32. PubMed ID: 10772415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
    Park YJ; Shin KH; Park JG
    Clin Cancer Res; 2000 Aug; 6(8):2994-8. PubMed ID: 10955776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of endometrial cancer meeting new clinical criteria for hereditary nonpolyposis colorectal cancer.
    Sagawa T; Yamada H; Yamamoto R; Sakuragi N; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):327-31. PubMed ID: 11063667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial factors and genetic predisposition to cancer: population studies.
    Lynch HT; Lynch JF
    Cancer Detect Prev; 1991; 15(1):49-57. PubMed ID: 2044075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.